Novo Nordisk International Operations Commits to Veeva Vault CRM

Rhea-AI Summary

Veeva Systems (NYSE: VEEV) announced that Novo Nordisk's International Operations has committed to adopt Veeva Vault CRM to support commercial teams with next‑generation CRM capabilities and agentic AI.

Vault CRM is described as part of a suite of applications and agentic AI designed for commercial execution across personal and digital channels and to address global, country‑specific business and compliance requirements. Both companies framed the move as an expansion of their strategic partnership and a technology foundation to help drive commercial execution.

News Market Reaction

+0.62%

1 alert

+0.62% News Effect

On the day this news was published, VEEV gained 0.62%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Share price: $237.87 Daily move: 7.48% Trading volume: 3,030,554 shares +5 more

8 metrics

Share price $237.87 Pre-news current price for VEEV

Daily move 7.48% Pre-news 24h price change for VEEV

Trading volume 3,030,554 shares Today vs 20-day average of 1,656,486

52-week range $201.54–$310.50 VEEV price range over past 52 weeks

Market cap $36,380,992,149 VEEV pre-news equity valuation

Q3 FY26 revenue $811.2M Fiscal 2026 third quarter total revenue, up 16% YoY

Q3 FY26 subscription $682.5M Fiscal 2026 Q3 subscription services revenue, up 17% YoY

Share repurchase $2.0B Board-authorized Class A common stock repurchase program term of 2 years

Market Reality Check

Price: $203.92 Vol: Volume 3,030,554 is 1.83x...

high vol

$203.92 Last Close

Volume Volume 3,030,554 is 1.83x the 20-day average of 1,656,486, indicating elevated interest pre-news. high

Technical Price 237.87 is trading below the 200-day MA of 263.52, despite a 7.48% daily gain.

Peers on Argus

While VEEV gained 7.48%, peers showed mixed moves: TEM +4.78%, WAY +2.36%, HQY +...

While VEEV gained 7.48%, peers showed mixed moves: TEM +4.78%, WAY +2.36%, HQY +2.54%, GEHC +2.28%, and DOCS -0.57%, suggesting a stock-specific reaction to the Novo Nordisk CRM commitment.

Historical Context

5 past events · Latest: Jan 05 (Positive)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Jan 05	Share repurchase plan	Positive	+0.8%	Board authorized up to <b>$2.0B</b> in Class A share repurchases.
Dec 04	Investor conference	Neutral	-0.1%	Announcement of participation in Raymond James 2025 TMT and Consumer Conference.
Dec 03	AI product launch	Positive	+0.5%	Launch of Veeva AI Agents for Vault CRM and PromoMats to boost productivity.
Nov 24	Pharma partnership	Positive	-3.4%	Roche to adopt Veeva Vault CRM across its global pharma organization.
Nov 20	Quarterly earnings	Positive	-0.9%	Fiscal 2026 Q3 results with strong revenue and income growth plus AI progress.

Pattern Detected

Recent positive strategic and AI/product announcements have produced mixed price reactions, with some major partnership and earnings updates seeing negative next-day moves.

Recent Company History

Over the last few months, Veeva reported strong fiscal 2026 Q3 results with total revenues of $811.2M and subscription services of $682.5M, alongside double-digit growth in operating and net income. It expanded its AI footprint with Veeva AI Agents for Vault CRM and PromoMats and announced an expanded Vault CRM partnership with Roche. The Board also authorized a $2.0 billion share repurchase program. Today’s Novo Nordisk Vault CRM commitment extends this pattern of large pharma adopting Vault and Veeva’s agentic AI capabilities.

Market Pulse Summary

This announcement extends Veeva’s momentum in deploying Vault CRM and agentic AI across large pharma...

Analysis

This announcement extends Veeva’s momentum in deploying Vault CRM and agentic AI across large pharma, adding Novo Nordisk’s International Operations to prior wins like Roche. It builds on strong fiscal 2026 Q3 results with revenues of $811.2M and a $2.0B share repurchase authorization, underscoring a strategy focused on durable, high-value customer relationships. Investors may watch for additional Vault CRM adoptions, progress in Veeva AI Agents, and any disclosures on contract scope or financial contribution over time.

Key Terms

crm, agentic ai

2 terms

crm technical

"Chooses industry leading Vault CRM to empower commercial teams"

Customer relationship management (CRM) is the set of tools, practices and software companies use to track and manage interactions with customers and potential customers, like an organized digital address book combined with a sales coach. It matters to investors because effective CRM systems can boost sales, improve customer retention and lower marketing costs, which directly affects revenue growth and profit margins — key drivers of a company’s value.

agentic ai technical

"Vault CRM Suite of deep applications and agentic AI that drive"

Agentic AI refers to computer systems that can make their own decisions and take actions without needing someone to tell them what to do each time. It's like giving a robot a degree of independence to solve problems or achieve goals on its own, which matters because it could change how we work and interact with technology in everyday life.

AI-generated analysis. Not financial advice.

Chooses industry leading Vault CRM to empower commercial teams with next-generation CRM capabilities and agentic AI

PLEASANTON, Calif., Jan. 7, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Novo Nordisk's International Operations business unit has committed to use Veeva Vault CRM.

"We are honored to expand our partnership with Novo Nordisk to Vault CRM," said Veeva CEO Peter Gassner. "Working together with AI-driven technology, we will do our part to help Novo Nordisk deliver breakthrough medicines to defeat serious chronic diseases and create long-term health for patients around the world."

Vault CRM is part of the Vault CRM Suite of deep applications and agentic AI that drive more effective commercial execution across personal and digital channels. With advanced global capabilities, Vault CRM Suite addresses the industry's unique and evolving country-specific business and compliance requirements.

"We are excited to expand our strategic partnership with Veeva by moving to Vault CRM," said Emil Kongshøj Larsen, executive vice president, International Operations at Novo Nordisk. "Vault CRM will help provide Novo Nordisk the technology foundation to help drive commercial execution."

For all the latest information on Veeva Vault CRM with agentic AI visit veeva.com/CRM and connect with Veeva on LinkedIn.

About Veeva Systems
Veeva delivers the industry cloud for life sciences with software, data, and business consulting. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,500 customers, ranging from the world's largest biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.

Veeva Forward-Looking Statements
This release contains forward-looking statements regarding Veeva's products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the period ended October 31, 2025, which you can find here (a summary of risks which may impact our business can be found on pages 33 and 34), and in our subsequent SEC filings, which you can access at sec.gov.

Contact:

Maria Scurry
Veeva Systems
maria.scurry@veeva.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/novo-nordisk-international-operations-commits-to-veeva-vault-crm-302654654.html

SOURCE Veeva Systems

FAQ

What did Novo Nordisk announce about adopting Vault CRM with symbol VEEV on January 7, 2026?

Novo Nordisk's International Operations committed to use Veeva Vault CRM to support commercial teams and expand the companies' strategic partnership.

How does Veeva describe Vault CRM in the January 7, 2026 announcement (VEEV)?

Veeva described Vault CRM as part of a suite of deep applications and agentic AI for personal and digital commercial channels and country‑specific compliance.

Will Vault CRM address global compliance needs for Novo Nordisk according to VEEV's January 7, 2026 release?

Yes; the announcement says Vault CRM Suite addresses industry and country‑specific business and compliance requirements.

Does the January 7, 2026 announcement state a contract value or implementation timeline for Novo Nordisk and VEEV?

No; the announcement confirms a commitment to use Vault CRM but does not disclose contract value or implementation timing.

What benefits did executives cite for Novo Nordisk moving to Vault CRM in the VEEV announcement?

Executives said Vault CRM will provide a technology foundation to help drive commercial execution and support delivery of medicines to patients.

Where can investors find more information about Veeva Vault CRM mentioned in the January 7, 2026 release?

The announcement directs readers to visit veeva.com/CRM and connect with Veeva on LinkedIn for more information.